Patent details

EP1417227 Title: PEPTIDES EEFECTIVE IN THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS

Basic Information

Publication number:
EP1417227
PCT Application Number:
PCT/CA/2002/001105
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027485168
PCT Publication Number:
WO/2003/008443
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PEPTIDES EEFECTIVE IN THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS
French Title of Invention:
PEPTIDES EFFICACES DANS LE TRAITEMENT DE TUMEURS ET D'AUTRES ETATS PATHOLOGIQUES NECESSITANT L'ABLATION OU LA DESTRUCTION DE CELLULES
German Title of Invention:
PEPTIDE FÜR DIE BEHANDLUNG VON TUMOREN UND ANDEREN ZUSTÄNDEN, DIE DAS ENTFERNEN ODER ZERSTÖREN VON ZELLEN ERFORDERN
SPC Number:

Dates

Filing date:
19/07/2002
Grant date:
10/01/2007
EP Publication Date:
10/01/2007
PCT Publication Date:
30/01/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/05/2004
EP B1 Publication Date:
10/01/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/07/2017
Expiration date:
19/07/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/07/2002
 
 

Name:
NYMOX CORPORATION
Address:
9900 Blvd., Cavendish, Suite 306, St. Laurent Québec H4M 3V2, Canada (CA)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
11/04/2007
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
AVERBACK Paul, A.
Address:
Canada (CA)

Priority

1

Priority Number:
306161 P
Priority Date:
19/07/2001
Priority Country:
United States (US)

2

Priority Number:
306150 P
Priority Date:
19/07/2001
Priority Country:
United States (US)

3

Priority Number:
331477 P
Priority Date:
16/11/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 14/47;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
25/01/2017
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
30/11/2017 Outgoing Correspondence 1